Home
Discovery Engines
Team
Portfolio
Offices
News
← View News
May 16, 2019
Tempest Therapeutics Starts Phase I/Ib Clinical Trial with First-in-Class PPAR Alpha Antagonist
Download PDF
Media Contact
Steve Edelson
(415) 801-8088
[email protected]